.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
US Army
Cerilliant
Farmers Insurance
UBS
Cantor Fitzgerald
US Department of Justice
AstraZeneca
Novartis
Mallinckrodt

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Try a Free Trial

« Back to Dashboard

Details for Patent: ➤ Try a Free Trial

Title: Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
Abstract:The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
Inventor(s): Bieniarz; Christopher (Highland Park, IL), Chang; Steve H. (Gurnee, IL), Cromack; Keith R. (Lake Bluff, IL), Huang; Shuyen L. (Riverwoods, IL), Kawai; Toshikazu (Saitama, JP), Kobayashi; Manami (Saitama, JP), Loffredo; David (Elmhurst, IL), Raghavan; Rajagopalan (Grayslake, IL), Speicher; Earl R. (Buffalo Grove, IL), Stelmach; Honorats A. (Lake Forest, IL)
Assignee: Abbott Laboratories (Abbott Park, IL)
Filing Date:Jul 03, 2002
Application Number:10/190,271
Claims:1. A method for storing a quantity of sevoflurane, the method comprising the steps of: providing a container defining an interior space, said container having an interior wall adjacent said interior spaced defined by said container; providing a quantity of sevoflurane; coating said interior wall of said container with a Lewis acid inhibitor; placing said quantity of sevoflurane in said interior space defined by said container.

2. A method for storing a quantity of sevoflurane in accordance with claim 1, wherein said Lewis acid inhibitor is selected from the group consisting of water, butylated hydroxytoluene, methylparaben, propylparaben, propofol, and thymol.

3. A method for storing a quantity of sevoflurane in accordance with claim 1, wherein said Lewis acid inhibitor is water.

4. A method for storing a quantity of sevoflurane in accordance with claim 1, wherein said Lewis acid inhibitor is water saturated sevoflurane.

5. The method of claim 1 wherein the step of coating said interior wall of said container is accomplished by washing or rinsing said interior wall of said container with said Lewis acid inhibitor prior to filling said container with said quantity of sevoflurane.

6. The method of claim 5 wherein said Lewis acid inhibitor is water.

7. A method for storing a quantity of sevoflurane in accordance with claim 5, wherein said Lewis acid inhibitor is water saturated sevoflurane.

8. The method of claim 6 wherein said container is partially dried between the rinsing and filling steps.

9. The method of claim 2 wherein the step of coating said interior wall of said container is accomplished by placing said container in a humidity chamber for a sufficient time to allow said Lewis acid inhibitor to accumulate in said container in an amount effective to prevent degradation by a Lewis acid of said quantity of sevoflurane.

10. The method of claim 9 wherein said Lewis acid inhibitor is water.

11. A sevoflurane product protected from degradation by Lewis acids in accordance with the method of claim 1.

12. A sevoflurane product protected from degradation by Lewis acids in accordnace with the method of claim 2.

13. A sevoflurane product protected from degradation by Lewis acids in accordnace with the method of claim 3.

14. A sevoflurane product protected from degradation by Lewis acids in accordnace with the method of claim 4.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Fuji
Federal Trade Commission
Julphar
QuintilesIMS
Mallinckrodt
UBS
Citi
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot